close
Request a Demo
Vocantas News

Ride For Dad Sees Value in Interactive Patient Follow Up

On May 4th, more than 300 men in Ottawa received a free PSA test courtesy of the Ride For Dad and The Ottawa Hospital Foundation. Vocantas was proud to be a sponsor of the event, providing every man that received a test that day with an interactive follow up phone call to provide test result information.

Monday June 24, 2013

On May 4th, more than 300 men in Ottawa received a free PSA test courtesy of the Ride For Dad and The Ottawa Hospital Foundation.  Vocantas was proud to be a sponsor of the event, providing every man that received a test that day with an interactive follow up phone call to provide test result information.

Garry Janz, Co-founder and President of Ride For Dad, said “I was not a believer in the beginning. I didn’t think that reaching out to our clinic attendees with an automated call would be well received. What I realized when I received the call myself was the efficiency and value in having an automated system. Instead of waiting weeks for results, our clinic attendees now had follow-up within 48 hours of their PSA test and we could connect with every man that attended and interact to collect some valuable data.”

Ride For Dad, The Ottawa Hospital Foundation and Vocantas are proud to partner and work together to provide this important PSA clinic for men in our community. The Vocantas solution has been and will be providing the interactive follow up calls to PSA clinic attendees. The Vocantas product, CallAssure™, calls patients in a real human voice from an automated telephone system. Using information in the database the system dynamically pulls the patient’s individual information and provides an interactive experience to ensure the patient fully understands the information given. Ride For Dad can then see statistics about calls made and interactions that took place. Patient feedback is provided in aggregate form to help organizations collect valuable patient input.

The system is not only 100% reliable, but is consistent in tone, voice and message. Whereas a human making repeated calls will experience fatigue and may interpret results incorrectly or provide incorrect data to the patient, the automated system never makes a mistake. Patients receive phone calls in the evening when they are more likely to be home, and the system detects and redirects when voicemail or answering machines are detected.

Prostate cancer is the most common cancer affecting Canadian men. A Prostate-Specific Antigen (PSA) test is one of the simplest and quickest ways to help detect prostate cancer in men.  With early detection, 90 per cent of cases can be treated. The few minutes spent getting the test might end up saving your life!

Stay Connected!

Subscribe to our newsletter and receive all our news and updates.

    Vocantas News

    Latest News
    From Vocantas

    Read about the latest updates from Vocantas.

    View All News
    Wednesday April 17, 2024

    Feature Release – Supercharged API Tools and Partner Integration Enhancements

      Vocantas is pleased to announce its latest 5.8 Automated Shift Filling release, offering integration enhancements for Dayforce and UKG …

    Feature Release – Supercharged API Tools and Partner Integration Enhancements Read More »

    Friday February 9, 2024

    Feature Release: Fill Shifts Even Faster With Vocantas’s Latest UKG Pro WFM Integration Enhancements

    Vocantas is excited to announce its latest Automated Shift Filling release, which offers a more comprehensive integration with UKG Pro …

    Feature Release: Fill Shifts Even Faster With Vocantas’s Latest UKG Pro WFM Integration Enhancements Read More »

    Monday November 15, 2021

    Vocantas Announces Marina Avisar as new CEO

    Vocantas, an innovator in workforce management communications, is pleased to announce the appointment of Marina Avisar as the new CEO …

    Vocantas Announces Marina Avisar as new CEO Read More »

      Request a Quote

      Fill out the form and we will send you details about our demo.